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CHAPTER fIfTEEN 
Division of Nephrology 
MICHAEL L. SIMENHOFF, M.D. 
((It is no exaggeration to say that the 
composition of the blood is determined 
not by what the mouth takes in but by 
what the kidneys keep.)) -HOMER W. SMITH (1895-1962) 
Early Nephrology at Jefferson 
Nephrology has been relatively a latecomer to the 
disciplines of medicine as a whole. The major 
impetus came from the development of an 
artificial kidney by William Kolff, M.D., in 
Holland during World War II. This advance in 
turn derived from a series of technological steps, 
the first of which was the use by Abel, Rountree, 
and Turner in 1913 of hemodialysis to remove urea 
in dogs. The organization of Nephrology into a 
separate Division of the Department of Medicine 
began at Jefferson only in 1962 when Laurence G. 
Wesson, Jr., was appointed Professor of Medicine 
and Head of the Division of Nephrology. Before 
this, in the late 1950S and early 1960S, Dr. Janles 
E. Clark (Jefferson, 1952) had acquired an artificial 
kidney for hemodialysis in order to study adrenal 
problems, but this machine was soon COlnman-
deered to treat iU patients with acute renal failure. 
He held together the loose discipline of renology 
alone with the services of a small supplementary 
laboratory adjacent to the room that housed the 
artificial "kidney unit." Although peritoneal 
dialysis had been performed a few times in the 
1950S, it was not an established procedure for use 
in acute renal failure. 
Dr. Clark (Figure 15-1), together with Dr. John 
Y. Templeton III, (Jefferson, 194-1), explored the 
use of isolated intestinal loops as an alternative 
functioning membrane to rid the body of uremic 
toxins, fluid, and electrolytes. A generous grant 
was obtained from the John A. Hartford 
Foundation for this study, and Dr. Miles H. 
Sigler, Associate Professor of Medicine, became 
involved in the kinetics of sodium and glucose 
transport across the intestinal membrane. Dr. 
Herbert E. Cohn (Jefferson, 1955), Associate 
Professor of Surgery, perfected the surgical 
techniques for creating the isolated small intestinal 
loops in man and continued the study. It soon 
became clear, however, that the intestinal mucosa 
was much too discriminating a barrier for dialysis. 
Uremic toxins other than urea and sodium could 
not be removed adequately, and uremic patients 
with loops came to need hemodialysis as much as 
patients without loops. In order to keep loop 
patients well enough to permit studies, a chronic 
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dialysis unit had to be created within the Hartford 
Foundation research program. Just as one research 
program had led to the establishment of the earlier 
acute dialysis unit, so another research program 
now led to the creation of a chronic dialysis unit. 
Dr. Wesson (Figure 15-2) had been recruited 
from the New York University Graduate School of 
Medicine. He had spent 15 years in close 
collaboration with Dr. Homer Smith, one of the 
pioneers of Physiological Nephrology, and himself 
had been instrumental in developing the concept 
of osmolar and free water clearance by the kidney. 
There was much enthusiasm in the arrival of Dr. 
Wesson to develop a superior nephrology 
program, particularly with the presence of the 
Clinical Research Center as well as available space 
and funds. Dr. Joseph Letteri was appointed 
Research Fellow in Medicine in January of 1962 to 
further this project. 
Dr. Clark continued as the major renal clinician 
and gradually dissociated himself from his previous 
private partnership practice because of the time 
commitments to the nephrology program. He was 
supported by the dialyzer and research funds to 
obtain a technician. No one at Jefferson had 
special training or extensive experience related to 
renal problems beyond that of a general internist 
except Dr. F.W. Sunderman, Sr., who headed a 
small unit recognized as a chemical section but not 
a Division of Medicine. He was often asked to 
consult on electrolyte, water, and acid-base 
problems. There was no teaching program, 
resident rotation, or student elective featuring the 
kidney as a discipline until Dr. Michael Simenhoff 
joined the Division in 1964. Simenhoff was 
recruited from Dr. John Merrill's program at the 
Peter Bent Brigham Hospital. As Assistant 
FIG. [5-2. Laurence G. Wesson, )f., M.D., Professor of 
FIG. [5-1. James E. Clark, M.D., a pioneer at Jefferson in Medicine and First Head of the Nephrology Division 
clinical nephrology and hemodialysis in the late I950S. ([962). 
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Director of the Clinical Research Center, he 
developed investigative studies in the diurnal 
rhythm of kidney function with Dr. Wesson. The 
Division was initially Renal Diseases in Fluid and 
Electrolyte Metabolism, next changed to Renal 
Disease, and finally to Nephrology in 1966. 
It is germane to put nephrology in perspective 
in Philadelphia in 1962 when the Division of 
Nephrology at Jefferson was initiated. Clinical 
nephrology was still part of General Internal 
Medicine. Kidney-related research at the 
University of Pennsylvania was mainly out of Dr. 
Russell Elkinton's chemical section, where Dr. 
Miles Sigler took a research fellowship. Dr. Lewis 
W. BluemJe, Jr., destined to become the President 
of Thomas Jefferson University in 1977, was an 
outstanding pioneer in nephrology at the 
University of Pennsylvania from 1946 to 1968, 
during which time he authored or coauthored 46 
articles in this field. Hahnemann Medical College 
had a renology section headed by Dr. Albert N. 
Brest, who subsequently came to Jefferson as 
Director of Cardiology. Neither Woman's Medical 
CoUege (later Medical College of Pennsylvania) 
nor Temple Medical School had anything going in 
tl1e line of nephrology. This paucity of nephrology 
services in the early 1960s soon changed, and 
nephrology as a subspecialty deVeloped rapidly in 
many of the community as well as university 
hospitals. 
At this time, there was an institutional move to 
obtain a general clinical research center for 
Jefferson. A committee of Drs. Wise, Sodeman, 
Gibbon, and Cantarow directed this effort but 
could find no candidate for Director. Because of 
Dr. Wesson's reputation he was urged to accept 
the position in addition to his responsibilities as 
Director of tl1e Division of Nephrology. 
.'\round 1964, Dr. Herbert Cohn became 
interested in renal transplantation, and a few were 
performed, but there was no major institutional 
commitment in this area. Later, in 1972, Dr. Harry 
Goldsmith, Chairman of the Department of 
Surgery, recruited Dr. James Colberg as Chief of 
the surgical arm of the transplantation program. 
• Refinement of Dialysis Technology 
With the departure of Dr. Clark in 1968 to 
become the Chief of Medicine at Crozer Chester 
Hospital, Dr. Norman Lasker came to Jefferson in 
1969 as Director of the Dialysis Unit. Dr. Lasker 
continued the development and expansion of the 
Unit and introduced new dialysis technologies and 
services, particularly in me area of peritoneal 
dialysis. Together with Dr. Bruce E. Jarrell 
(Jefferson, 1973), a peritoneal dialysis cycler was 
developed. Patients could thus be dialyzed while 
they were sleeping at night with an automated 
system. In 1971 the Clinical Research Center was 
discontinued, and many of the clinical investigative 
programs carried out in the Center had to be 
abandoned. In 1971, Dr. James F. Burke, Jr. 
(Jefferson, 1966) (Figure 15-3) was appointed to 
the faculty to assist Dr. Lasker in the dialysis 
program. In 1973 tl1e Tsaltas dialysis unit with six 
beds was established, which was responsible for 
approximately 2,000 dialyses per year. Dr. 
Theodore Tsaltas, who was Professor of Pathology 
at Jefferson, had been a patient on chronic dialysis 
and the Center was nan1ed in his honor. 
The Early Renal Transplantation 
Program 
At this time, Dr. James E. Colberg was appointed 
to head me surgical arm of the transplant 
program. Dr. Steven Bulova was also appointed to 
run me tissue typing laboratory and perform me 
mixed lymphocyte cultures, procedures mat were 
men important in selecting donors for renal 
transplantation. In those years approximately ten 
transplants were performed per year. 
Prior to Dr. Lasker's coming, in me late 1960s 
an electron microscopy unit was set up wim Dr. 
Serge W. Duckett in neuropathology. Soon after, 
Dr. Rum P. Gottlieb, a pediatric nephrologist in 
me Department of Pediatrics and active in the 
nephrology programs, established a fluorescent 
microscopy laboratory so mat these techniques 
could be used to detect antibody deposition in 
renal tissues. Thus at mis time renal biopsy 
services incorporated light, electron, and 
fluorescent microscopical analysis, and wide-range 
diagnostic services became available. 
In 1973 to 1974, while Dr. Michael Simenhoff 
was on sabbatical leave in London studying amine 
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metabolism in uremia at the laboratories of Dr. 
Malcome Milne at Westminister Hospital Medical 
School in the University of London, Dr. Laurence 
Wesson decided to resign his position as Director. 
On his return, Dr. Simenhoff as made Acting 
Director, and Director in July 1975. At this time 
Dr. Anatole Besarab joined the Division with a 
secondary appointment in the Department of 
Physiology. Dr. Besarab had been trained under 
Dr. Franklin Epstein, an internationally known 
nephrologist at Harvard Medical School, where 
Dr. Besarab had learned the technique of 
perfusing isolated rat kidney. under variou~ . 
physiological and pathophysIOlogICal conditions. 
Dr. Besarab's expertise, together with Dr. . 
Wesson's background in this area, led to National 
Institutes of Health funding. Dr. Besarab studied 
the interrelationship of calcium, parathyroid 
hormone, and cyclic AMP, and also made 
contributions in the better understanding of 
transplantation nephropathy. This, combined with 
Dr. SimenhofPs funding for the production of 
carcinogenic nitrosamines in patients with chronic 
renal failure, also now funded by NIH, and Dr. 
Wesson's continued Career Award from the 
National Institutes of Health, gave the Division a 
solid base of support for basic research in the 
Division. Dr. Wesson continued his research 
studies on the preservation methods of the isolated 
kidney. 
FIG. 15-3. James F. Burke, Jr., M.D., Professor of 
Medicine; nephrologist for renal transplantation program. 
• Growth of Renal Transplantation 
The transplantation program accelerated with the 
recmitment of Dr. Bruce E. Jarrell in 1980. Dr. 
Jarrell's background in engineering had already 
facilitated contributions to the developmem of the 
cycling peritoneal dialysis machine pr~viously 
mentioned, and his ability and enthusiasm gave 
new life to what had been a stagnant transplan-
tation program. With Dr. James Burke as the 
nephrology arm of the program ~nd Dr. Jarrell on 
the surgical side, the transplantation prog:am grew 
vigorously, with physici.an referrals sta~ewlde and 
from nonaffiliated hospitals. With partiCIpation of 
Dr. Besarab many clinical studies were performed 
in the transplantation field, and at the basic level 
Dr. Jarrell was funded for studies on the role of 
the endothelial cell in transplantation rejection. 
The nwnber of transplants per year rose to 80. 
As the clinical services continued to grow in the 
1980s it became essential to recmit additional 
personnel. Dr. Norman La~ker bad left Jefferson 
in 1979 to take up an appomtment as head of the 
Division of Nephrology at the New Jersey College 
of Medicine in Newark. Dr. Burke became head 
of the Dialysis Unit, but with the growing 
transplantation progr~, it b~c~e c1~ear that the 
Division needed a fuU-tlIne dialySIS director apart 
from the transplantation group. .. 
Dr. Nancy B. Jcrmanovich was recnuted m July 
of 1982 to bolster the clinical services but mainly 
to develop a program in experimental 
glomerulonephritis, an area that had no.t been 
previously developed. With the emphaSIS on , 
dialysis and with more than 60 percent of pa.nents 
on chronic dialysis (having glomerulonephritis as 
the etiology of the renal disease), it w~s. felt that 
this was an important area for the DIvISion to 
develop. Dr. Jermanovich came from New York 
State University at Syracuse and had been, tramed 
by Dr. Willianl Couser at Boston UI1IVerslty 
during her fellowship. Arrangme,nts ha~ been 
made with the Department of BIOchemistry. to 
interdigitate her interests in immunology With 
those of the Deparunent of Biochemistry. 
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Soon after this, Dr. George C. Francos 
(Jefferson, 1978), who had come through the 
Jefferson ranks, including a Fellowship, was 
appointed to the Division and to be the Director 
of the chronic dialysis program. The dialysis 
program was still growing, and the facilities at the 
Health Science Building on Ninth and Sansom 
Streets containing 12 stations for three daily shifts 
had already become cramped. Both hemodialysis 
and peritoneal dialysis modalities were offered, 
with emphasis on in-Center hemodialysis and 
continuous ambulatory peritoneal dialysis (CAPD). 
The history of the nephrology programs at the 
affiliated hospitals was one of gradual 
independence, so that each of them acquired 
free-standing independent nephrology units. 
Earlier, intermittent involvement at Jefferson by 
Dr. Miles Sigler (Lankenau Hospital), Dr. John T. 
Magee (Jefferson, 1957; Bryn Mawr Hospital), Dr. 
Robert B. Flinn (Wilmington Medical Center), 
and Dr. John P. Capelli (Jefferson, 1962; Our 
Lady of Lourdes Hospital) had resulted in 
independent units of high caliber. This was 
benefIcial in the teaching of Jefferson medical 
students and house officers when they rotated 
through these affiliated hospitals. The affiliated 
nephrology programs became important sources 
for transplantation referral. 
Progress in the prevention and treatment of 
renal diseases has not only saved lives but 
provided a normal life span for many of its 
unfortunate victims. 
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CHAPTER SIXTEEN 
Division of Medical 
Oncology 
WILLIAM E. DELANEY, M.D. 
((While there are several chronic diseases 
more destructive to life than cancer, 
none is more feared.J) -CHARLES H. MAYO (l865-1939) 
A1:rHOUGH medical oncology was first officially recognized as a medical subspecialty by the American Board of 
Internal Medicine in 1972, a formal Division of 
Medical Oncology in the Department of Medicine 
at Jefferson had been established since 1961. The 
first Director (1961-1970) was Arthur Weiss, M.D. 
(Figure 16-1), and the second (1970-1980) was 
Chester Southam, M.D. (Figure 16-2). Acting 
Directors were William E. Delaney, M.D. 
(Jefferson, 1953; 1980-1981) and J. Frederick 
Laucius, M.D. (Jefferson, 1967; 1981-1984-). The 
third Director is Michael J. Mastrangelo, M.D., 
appointed in 1984-. 
The major activities of the Division since its 
inception have been patient care, teaching, 
research, and the training of medical oncology 
Fellows. Among the latter, the first Fellows were 
Laird Jackson, M.D., who was the first National 
Institutes of Health Postdoctoral Fellow (1961-
1962), and Harvey Brodovsky, M.D. (1961-1963). 
Several additional Fellows have served in the 
Division since that time, most notably Carla 
Goepp, M.D. (Figure 16-3), (1965-1967), who 
became Associate Dean of Student Affairs and 
Director of the Office of Student Counseling and 
Career Planning, and Michael J. Mastrangelo, 
M. D. (1968-1970). Significant accomplishments in 
cancer care, research, and teaching at Jefferson 
occurred in the years before the establislunent of 
the Division. 
The Tumor Clinic and Elizabeth 
Storck I(raemer Foundation 
The Tumor Clinic was informally begun in 1928 
and has continued since that date as the major 
institutional follow-up mechanism for cancer 
patients. Formal establishment began in the fall of 
1929 when, through the auspices of William H. 
Kraemer, M.D. (Figure 10-4-, Jefferson, 1906), 
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